YingJing TECH-RD

Product development & Quality control

넳 넲

R&D Center

The Company has established an open technology platform dedicated to creating a technological empowerment platform for the pharmaceutical health industry, aspiring to facilitate API manufacturing companies, pharmaceutical production enterprises, chemical manufacturing companies, and entrepreneurs to lower R&D thresholds, improve R&D efficiency, and facilitate the early introduction of more new and effective drugs to benefit patients globally. The Company has established two major R&D centers in Guangzhou and Wuhan, mainly engaged in the R&D of APIs, pharmaceutical intermediates, pharmaceutical preparations, and fine chemical products. The Wuhan R&D center spans an area of 1,500 square meters, housing over 150 R&D personnel, including nine doctor’s degree holders and 41 master’s degree holders. Over 95% of the employees have at least a bachelor’s degree. Our platform currently supports over 100 R&D projects from more than 50 partners. We have pre-production test and large-scale production bases in Chifeng City, Inner Mongolia, China.

Adhering to the quality management philosophy, that is "responsibility, precise control, superior quality, international standard", Yingjing conscientiously implements the ISO9001 quality management system, "Good Manufacturing Practice", "Drug Administration Law", "Product Quality Law", ICH Q7a, EU GMP, FDA, cGMP and other relevant laws and regulations, and establish and operate the quality management system according to the laws and regulations .